يعرض 1 - 10 نتائج من 46 نتيجة بحث عن '"Maria Pia Sormani"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies

    المؤلفون: Gavin Giovannoni, Patricia K. Coyle, Andrew Galazka, Thomas Leist, Nektaria Alexandri, Fernando Dangond, B. Keller, Kottil Rammohan, Maria Pia Sormani, Nicola De Stefano

    المصدر: Multiple Sclerosis (Houndmills, Basingstoke, England)

    مصطلحات موضوعية: relapses, medicine.medical_specialty, Multiple Sclerosis, cladribine tablets, Placebo, law.invention, 03 medical and health sciences, Multiple Sclerosis, Relapsing-Remitting, disease-modifying therapy, hospitalisation, Relapsing-remitting multiple sclerosis, steroids, 0302 clinical medicine, Recurrence, law, Internal medicine, medicine, Humans, 030212 general & internal medicine, Cladribine, business.industry, Multiple sclerosis, medicine.disease, Neurology, CLARITY, Neurology (clinical), business, Original Research Papers, Immunosuppressive Agents, 030217 neurology & neurosurgery, Tablets, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bf8cb96eae26b3d90b6e16cab1eba15Test
    https://doi.org/10.1177/13524585211010294Test


    أضف إلى المفضلة
  2. 2
    Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis

    المؤلفون: Maria Pia Sormani, Jos Kleijnen, Elizabeth Kinter, Gavin Giovannoni, Shona H. Lang, Robert Hyde, Robert Wolff, Steven Duffy, Craig Wakeford

    المصدر: Neurology and Therapy, Vol 9, Iss 2, Pp 335-358 (2020)
    Neurology and Therapy

    مصطلحات موضوعية: medicine.medical_specialty, INTERFERON-BETA, NETWORK METAANALYSIS, DIAGNOSTIC-CRITERIA, ISPOR TASK-FORCE, Population, Psychological intervention, Review, Multiple sclerosis, 03 medical and health sciences, 0302 clinical medicine, Mixed treatment comparison, Health care, CARE DECISION-MAKING, medicine, 030212 general & internal medicine, Imputation (statistics), RC346-429, Intensive care medicine, education, GLATIRAMER ACETATE, education.field_of_study, Relapsing–remitting multiple sclerosis, Healthcare decision-making, business.industry, Outcome measures, Treatment options, META-ANALYSIS, EFFICACY, medicine.disease, Neurology, DIMETHYL FUMARATE, Meta-analysis, DISEASE-MODIFYING THERAPIES, Relapsing-remitting multiple sclerosis, Neurology. Diseases of the nervous system, Neurology (clinical), business, 030217 neurology & neurosurgery

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::486ce1dd5fda7ed09f425977a4eb0cf7Test
    https://doi.org/10.1007/s40120-020-00213-4Test


    أضف إلى المفضلة
  3. 3
    Prevalence of disability improvement as a potential outcome for multiple sclerosis trials

    المؤلفون: Matilde Inglese, Maria Pia Sormani, Maria Pia Amato, Alessio Signori, Giacomo Boffa, Gianluigi Mancardi, Alice Mariottini, A. Repice, Luca Massacesi, Riccardo Saccardi, Francesca Bovis

    المصدر: Multiple Sclerosis Journal. 27:706-711

    مصطلحات موضوعية: medicine.medical_specialty, Multiple Sclerosis, Transplantation, Autologous, Outcome (game theory), 03 medical and health sciences, Multiple Sclerosis, Relapsing-Remitting, 0302 clinical medicine, Prevalence, medicine, Humans, 030212 general & internal medicine, Intensive care medicine, clinical trials, long-term, Expanded Disability Status Scale, business.industry, Multiple sclerosis, medicine.disease, Disability improvement, outcome, prevalence, Clinical trial, Neurology, Disease Progression, Neurology (clinical), Neoplasm Recurrence, Local, business, 030217 neurology & neurosurgery

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523f33fe0474c9c5333b5de6ff9b3a81Test
    https://doi.org/10.1177/1352458520936236Test


    أضف إلى المفضلة
  4. 4
    Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey

    المؤلفون: Girolama Alessandra Marfia, Guglielmo Pacileo, Maria Pia Sormani, Giorgia Mataluni, Doriana Landi, Gaia Cola, Gianluca Cecchi, Alfonso Grimaldi, Marta Ponzano, Nicola Biagio Mercuri, Carolina Gabri Nicoletti

    المصدر: Neurological Sciences

    مصطلحات موضوعية: medicine.medical_specialty, Telemedicine, Coronavirus disease 2019 (COVID-19), COVID-19 pandemic, Dermatology, Settore MED/26, Multiple sclerosis, Remote monitoring, Survey, Televisit, 03 medical and health sciences, 0302 clinical medicine, Surveys and Questionnaires, Health care, medicine, Humans, 030212 general & internal medicine, Pandemics, Socioeconomic status, Internet, Point (typography), SARS-CoV-2, business.industry, COVID-19, Usability, General Medicine, medicine.disease, Psychiatry and Mental health, Family medicine, Original Article, The Internet, Neurology (clinical), business, Psychology, 030217 neurology & neurosurgery

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d21a0abd8243e1671ba1c8ac4a5659Test
    http://hdl.handle.net/2108/279969Test


    أضف إلى المفضلة
  5. 5
    Efficacy of early anti-inflammatory treatment with high doses IV Anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia

    المؤلفون: Alessia Angelelli, Maria Pia Sormani, Emanuele Pontali, Giancarlo Antonucci, Amedeo Montale, Gian Andrea Rollandi, Giovanni Cassola, Roberta Caorsi, Francesca Calautti, Marco Gattorno, Davide Buzzi, Stefano Volpi, Angelo Ravelli, Nicoletta Bobbio, Elisa Giambruno, Marta Bustaffa, Marco Castellaneta, Alessio Signori, Andrea Moscatelli, Francesca Tricerri, Ilaria Gueli, Marcello Feasi, Elio Castagnola

    المصدر: The Journal of Allergy and Clinical Immunology
    Journal of Allergy and Clinical Immunology

    مصطلحات موضوعية: 0301 basic medicine, Male, GC, glucocorticoids, Anti-Inflammatory Agents, Kaplan-Meier Estimate, Azithromycin, law.invention, Cohort Studies, chemistry.chemical_compound, 0302 clinical medicine, anakinra, COVID-19 pneumonia, early treatment, glucocorticoid, IL-1, law, FiO2, fraction of inspired oxygen, PaO2, partial pressure of oxygen, Medicine, Immunology and Allergy, 030212 general & internal medicine, Aged, 80 and over, Hazard ratio, Middle Aged, Intensive care unit, C-Reactive Protein, Treatment Outcome, Methylprednisolone, ICU, intensive care Unit, Italy, Injections, Intravenous, Disease Progression, Female, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Immunology, Article, Drug Administration Schedule, 03 medical and health sciences, Tocilizumab, Internal medicine, AIT, anti-inflammatory treatment, Humans, Glucocorticoids, Pandemics, ARDS, acute respiratory distress syndrome, Aged, Retrospective Studies, Anakinra, business.industry, SARS-CoV-2, COVID-19, Hydroxychloroquine, medicine.disease, SOC, standard of Care, Respiration, Artificial, MAS, macrophage activation syndrome, COVID-19 Drug Treatment, Pneumonia, Interleukin 1 Receptor Antagonist Protein, 030104 developmental biology, chemistry, business, interleukin-1

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bcc714e829a7142222fb95c003b1cedTest
    http://europepmc.org/articles/PMC7865089Test


    أضف إلى المفضلة
  6. 6
    Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas

    المؤلفون: Maria Pia Sormani, Aaron P. Tansy, Francesca Bovis, Alessio Signori, Thomas Li, Luca Carmisciano, Joshua R. Steinerman, Ilaria Maietta

    المصدر: Annals of Neurology. 84:621-625

    مصطلحات موضوعية: Expanded Disability Status Scale, business.industry, Multiple sclerosis, Disease progression, Psychological intervention, medicine.disease, Placebo, Eastern european, 03 medical and health sciences, 0302 clinical medicine, Neurology, Multiple sclerosis functional composite, Meta-analysis, medicine, 030212 general & internal medicine, Neurology (clinical), business, 030217 neurology & neurosurgery, Demography

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::053e97f9f2ea326aeac05235822b27b9Test
    https://doi.org/10.1002/ana.25323Test


    أضف إلى المفضلة
  7. 7
    Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?

    المؤلفون: Tomas Kalincik, Carmen Tur, Maria Pia Sormani

    مصطلحات موضوعية: medicine.medical_specialty, Multiple Sclerosis, Outcome Assessment, MEDLINE, 03 medical and health sciences, 0302 clinical medicine, Physical medicine and rehabilitation, Outcome Assessment, Health Care, Clinical endpoint, medicine, Humans, Disability progression, 030212 general & internal medicine, Expanded Disability Status Scale, business.industry, Multiple sclerosis, Reproducibility of Results, Multiple Sclerosis, Chronic Progressive, Disease Progression, Reference Standards, medicine.disease, Clinical trial, Health Care, Chronic Progressive, Neurology (clinical), business, 030217 neurology & neurosurgery

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a25797774724824bd867065ba91f31aTest
    http://hdl.handle.net/11567/1036938Test


    أضف إلى المفضلة
  8. 8
    MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a

    المؤلفون: Maria Pia Sormani, Nicola De Stefano, Ludwig Kappos, Julie Aldridge, Mark S. Freedman, Kurt Marhardt

    مصطلحات موضوعية: Clinical disease activity, Disability progression, Interferon beta-1a, MAGNIMS, Predictor of disease progression, Scoring system, medicine.medical_specialty, Multiple Sclerosis, Injections, Subcutaneous, Relapsing-Remitting, Gastroenterology, Injections, Disease Progression, Humans, Interferon-beta, Magnetic Resonance Imaging, Recurrence, Treatment Outcome, Multiple Sclerosis, Relapsing-Remitting, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, In patient, 030212 general & internal medicine, medicine.diagnostic_test, business.industry, Subcutaneous, Multiple sclerosis, Hazard ratio, Magnetic resonance imaging, General Medicine, medicine.disease, Clinical disease, Confidence interval, Neurology, Neurology (clinical), business, 030217 neurology & neurosurgery, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5096b8fac1a88a4b420f0b8df7b5d041Test
    http://hdl.handle.net/11365/1127379Test


    أضف إلى المفضلة
  9. 9
    Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy

    المؤلفون: Maria Pia Sormani, Antonio Carotenuto, Jessica Frau, Doriana Landi, Girolama Alessandra Marfia, Alessio Signori, Erica Curti, Francesco Saccà, Giorgia Teresa Maniscalco, Simone Cepparulo, Elisabetta Signoriello, Francesca Caleri, Mauro Zaffaroni, Damiano Baroncini, Carolina Gabri Nicoletti, Simona Bonavita, Giacomo Lus, Roberta Lanzillo, Viviana Nociti, Arianna Sartori

    المساهمون: Signoriello, E., Lus, G., Bonavita, S., Lanzillo, R., Sacca, F., Landi, D., Frau, J., Baroncini, D., Zaffaroni, M., Maniscalco, G. T., Curti, E., Sartori, A., Cepparulo, S., Marfia, G. A., Nicoletti, C. G., Carotenuto, A., Nociti, V., Caleri, F., Sormani, M. P., Signori, A., Signoriello, Elisabetta, Lus, Giacomo, Bonavita, Simona, Lanzillo, Roberta, Sacc??, Francesco, Landi, Doriana, Frau, Jessica, Baroncini, Damiano, Zaffaroni, Mauro, Teresa Maniscalco, Giorgia, Curti, Erica, Sartori, Arianna, Cepparulo, Simone, Alessandra Marfia, Girolama, Gabri Nicoletti, Carolina, Carotenuto, Antonio, Nociti, Viviana, Caleri, Francesca, Pia Sormani, Maria, Signori, Alessio

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Settore MED/26, Disease activity, Multiple sclerosis, 03 medical and health sciences, 0302 clinical medicine, Natalizumab, Multiple Sclerosis, Relapsing-Remitting, natalizumab, ocrelizumab, Internal medicine, medicine, Humans, Multiple sclerosi, 030212 general & internal medicine, Anti cd20, fingolimod, switch, Retrospective Studies, business.industry, Fingolimod Hydrochloride, medicine.disease, Fingolimod, Disease control, Neurology, Ocrelizumab, Neurology (clinical), business, 030217 neurology & neurosurgery, Immunosuppressive Agents, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e8b5692b507133ff49bea210b6257d8Test
    http://hdl.handle.net/11567/1045821Test


    أضف إلى المفضلة
  10. 10
    Rapid eye movement sleep behavior disorder: A proof-of-concept neuroprotection study for prodromal synucleinopathies

    المؤلفون: Beatrice Orso, Maria Pia Sormani, Flavio Nobili, Matteo Pardini, Riccardo Meli, Federico Massa, Pietro Mattioli, Nicola Girtler, Maria Isabella Donegani, Andrea Brugnolo, Francesco Famà, Matteo Bauckneht, Silvia Morbelli, Dario Arnaldi

    المصدر: European journal of neurologyREFERENCES. 28(4)

    مصطلحات موضوعية: Male, medicine.medical_specialty, Parkinson's disease, Synucleinopathies, Rapid eye movement sleep, REM Sleep Behavior Disorder, REM sleep behavior disorder, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Dementia, Humans, 030212 general & internal medicine, Aged, Tomography, Emission-Computed, Single-Photon, Dementia with Lewy bodies, business.industry, Parkinsonism, Putamen, Selegiline, Middle Aged, medicine.disease, Neuroprotection, Neurology, Female, Neurology (clinical), business, 030217 neurology & neurosurgery, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df054893723efd57dbff1bedd9400de2Test
    https://pubmed.ncbi.nlm.nih.gov/33275819Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث